Combined First Trimester Screening (CFTS) is a safe, non-invasive test performed between 11 and 13 weeks of pregnancy. It helps estimate your baby’s risk for common chromosomal conditions such as Down syndrome (Trisomy 21), Trisomy 18, and Trisomy 13 by combining ultrasound measurements with a simple blood test.
The ideal testing window is between 11 weeks and 13 weeks + 6 days of pregnancy. Scheduling outside this period may affect accuracy.
Yes. CFTS uses ultrasound and a maternal blood sample; there is no risk to the fetus.
A high-risk result means your baby may have a chromosomal condition. We recommend diagnostic testing (CVS or amniocentesis) for confirmation.
No fasting is required; you can eat and drink normally.
Results are typically available within 5–7 business days.
Coverage varies. Please check with your insurance provider for details.
Yes. Discuss with your doctor if you prefer cfDNA testing; it may offer higher accuracy but at higher cost.